These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21701793)

  • 1. Investigating the candidacy of lipopolysaccharide-based glycoconjugates as vaccines to combat Mannheimia haemolytica.
    St Michael F; Cairns C; Filion AL; Neelamegan D; Lacelle S; Cox AD
    Glycoconj J; 2011 Aug; 28(6):397-410. PubMed ID: 21701793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the potential of conserved inner core oligosaccharide regions of Moraxella catarrhalis lipopolysaccharide as vaccine antigens: accessibility and functional activity of monoclonal antibodies and glycoconjugate derived sera.
    Cox AD; St Michael F; Cairns CM; Lacelle S; Filion AL; Neelamegan D; Wenzel CQ; Horan H; Richards JC
    Glycoconj J; 2011 May; 28(3-4):165-82. PubMed ID: 21590368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: chemical strategies to prepare glycoconjugates with good carbohydrate loading.
    Cox AD; St Michael F; Neelamegan D; Lacelle S; Cairns C; Richards JC
    Glycoconj J; 2010 May; 27(4):401-17. PubMed ID: 20340043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of a D-glycero-D-manno-heptosyltransferase mutant of Mannheimia haemolytica displaying a veterinary pathogen specific conserved LPS structure; development and functionality of antibodies to this LPS structure.
    Logan SM; Chen W; Aubry A; Gidney MA; Lacelle S; St Michael F; Kuolee R; Higgins M; Neufeld S; Cox AD
    Vet Microbiol; 2006 Aug; 116(1-3):175-86. PubMed ID: 16750602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the candidacy of a lipoteichoic acid-based glycoconjugate as a vaccine to combat Clostridium difficile infection.
    Cox AD; St Michael F; Aubry A; Cairns CM; Strong PC; Hayes AC; Logan SM
    Glycoconj J; 2013 Dec; 30(9):843-55. PubMed ID: 23974722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: developmental chemistry and investigation of immunological responses following immunization of mice and rabbits.
    Cox AD; Zou W; Gidney MA; Lacelle S; Plested JS; Makepeace K; Wright JC; Coull PA; Moxon ER; Richards JC
    Vaccine; 2005 Oct; 23(43):5045-54. PubMed ID: 16046037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural analyses of the core oligosaccharide from the lipopolysaccharide of bovine and ovine strains of Mannheimia haemolytica serotype 2.
    St Michael F; Vinogradov E; Cox AD
    Carbohydr Res; 2011 Aug; 346(11):1333-6. PubMed ID: 21601179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: immunology of glycoconjugates with high carbohydrate loading.
    Cox AD; St Michael F; Neelamegan D; Lacelle S; Cairns CM; Giuliani MM; Biolchi A; Hoe JC; Moxon ER; Richards JC
    Glycoconj J; 2010 Oct; 27(7-9):643-8. PubMed ID: 20922476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and serological specificities of Pasteurella haemolytica lipopolysaccharides.
    Lacroix RP; Duncan JR; Jenkins RP; Leitch RA; Perry JA; Richards JC
    Infect Immun; 1993 Jan; 61(1):170-81. PubMed ID: 8418039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the candidacy of LPS-based glycoconjugates to prevent invasive meningococcal disease: conjugates based on core oligosaccharides.
    St Michael F; Cairns CM; Filion AL; Biolchi A; Brunelli B; Giuliani M; Richards JC; Cox AD
    Glycoconj J; 2014 Jan; 31(1):25-39. PubMed ID: 24013955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fatty acid composition of cells and lipopolysaccliarides of Mannheimia haemolytica, Mannheimia glucosida and Bibersteinia trehalosi strains].
    Vasiurenko ZP; Polishchuk EI; Ruban NM
    Mikrobiol Z; 2008; 70(6):42-6. PubMed ID: 19351048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of immunogenic outer membrane proteins from Mannheimia haemolytica serotype 1 by use of selective extraction and immunoaffinity chromatography.
    McVicker JK; Tabatabai LB
    Am J Vet Res; 2002 Dec; 63(12):1634-40. PubMed ID: 12492276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pasteurella multocida- and Pasteurella haemolytica-ghosts: new vaccine candidates.
    Marchart J; Dropmann G; Lechleitner S; Schlapp T; Wanner G; Szostak MP; Lubitz W
    Vaccine; 2003 Sep; 21(25-26):3988-97. PubMed ID: 12922135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain.
    Altman E; Chandan V; Harrison BA; Veloso-Pita R; Li J; KuoLee R; Chen W; Vérez-Bencomo V;
    Vaccine; 2012 Nov; 30(50):7332-41. PubMed ID: 22534169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and immunogenicity of Mannheimia haemolytica S1 outer membrane lipoprotein PlpF.
    Ayalew S; Shrestha B; Montelongo M; Wilson AE; Confer AW
    Vaccine; 2011 Nov; 29(47):8712-8. PubMed ID: 21875637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LKTA and PlpE small fragments fusion protein protect against Mannheimia haemolytica challenge.
    Guzmán-Brambila C; Quintero-Fabián S; González-Castillo C; de Obeso-Fernández del Valle Á; Flores-Samaniego B; de la Mora G; Rojas-Mayorquín AE; Ortuño-Sahagún D
    Res Vet Sci; 2012 Dec; 93(3):1293-300. PubMed ID: 22840333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide heterogeneity in Pasteurella haemolytica isolates from cattle and sheep.
    Ali Q; Davies RL; Parton R; Coote JG; Gibbs HA
    J Gen Microbiol; 1992 Oct; 138(10):2185-95. PubMed ID: 1282533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies to Pasteurella haemolytica serotype 1 lipopolysaccharide: demonstration of antigenic similarities among several serotypes.
    Durham JA; Antone SM; Cunningham MW; Confer AW
    J Clin Microbiol; 1988 May; 26(5):885-9. PubMed ID: 2454940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogens of Pasteurella.
    Confer AW
    Vet Microbiol; 1993 Nov; 37(3-4):353-68. PubMed ID: 8116191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross protection of a Mannheimia haemolytica A1 Lkt-/Pasteurella multocida ΔhyaE bovine respiratory disease vaccine against experimental challenge with Mannheimia haemolytica A6 in calves.
    Crouch CF; LaFleur R; Ramage C; Reddick D; Murray J; Donachie W; Francis MJ
    Vaccine; 2012 Mar; 30(13):2320-8. PubMed ID: 22306859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.